EP3283087A4 - Procédé et système de diagnostics et de traitements dérivés du microbiome pour des dysfonctionnements du système endocrinien - Google Patents

Procédé et système de diagnostics et de traitements dérivés du microbiome pour des dysfonctionnements du système endocrinien Download PDF

Info

Publication number
EP3283087A4
EP3283087A4 EP16780681.9A EP16780681A EP3283087A4 EP 3283087 A4 EP3283087 A4 EP 3283087A4 EP 16780681 A EP16780681 A EP 16780681A EP 3283087 A4 EP3283087 A4 EP 3283087A4
Authority
EP
European Patent Office
Prior art keywords
microbioma
diagnoses
dysfunctions
endocrine
treatments derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16780681.9A
Other languages
German (de)
English (en)
Other versions
EP3283087A1 (fr
Inventor
Zachary APTE
Daniel Almonacid
Jessica RICHMAN
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macrogen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3283087A1 publication Critical patent/EP3283087A1/fr
Publication of EP3283087A4 publication Critical patent/EP3283087A4/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Primary Health Care (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
EP16780681.9A 2015-04-14 2016-04-13 Procédé et système de diagnostics et de traitements dérivés du microbiome pour des dysfonctionnements du système endocrinien Pending EP3283087A4 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201562147355P 2015-04-14 2015-04-14
US201562147226P 2015-04-14 2015-04-14
US201562147058P 2015-04-14 2015-04-14
US201562147304P 2015-04-14 2015-04-14
US201562147202P 2015-04-14 2015-04-14
US201562147107P 2015-04-14 2015-04-14
US201562147348P 2015-04-14 2015-04-14
PCT/US2016/027378 WO2016168370A1 (fr) 2015-04-14 2016-04-13 Procédé et système de diagnostics et de traitements dérivés du microbiome pour des dysfonctionnements du système endocrinien

Publications (2)

Publication Number Publication Date
EP3283087A1 EP3283087A1 (fr) 2018-02-21
EP3283087A4 true EP3283087A4 (fr) 2019-03-13

Family

ID=57126198

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780681.9A Pending EP3283087A4 (fr) 2015-04-14 2016-04-13 Procédé et système de diagnostics et de traitements dérivés du microbiome pour des dysfonctionnements du système endocrinien

Country Status (4)

Country Link
EP (1) EP3283087A4 (fr)
CN (1) CN107708714B (fr)
AU (2) AU2016250159A1 (fr)
WO (1) WO2016168370A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3006057A1 (fr) * 2015-09-09 2017-03-16 uBiome, Inc. Methode et systeme de diagnostics et de therapies derives du microbiome destines a des affections associees a des problemes de sante de la thyroide
EP3766073A4 (fr) * 2018-03-16 2021-12-15 Psomagen, Inc. Procédé et système de caractérisation d'états associés au métabolisme, comprenant des diagnostics et des thérapies, sur la base d'une approche bioinformatique
CN114381507B (zh) * 2021-11-25 2024-02-13 杭州拓宏生物科技有限公司 格雷夫斯病标志微生物及其应用
WO2025131250A1 (fr) * 2023-12-19 2025-06-26 N.V. Nutricia Système et procédé d'analyse de matières fécales
CN119296652B (zh) * 2024-09-24 2025-10-21 河北大学 美国白蛾幼虫唾液及雌虫产卵分泌物效应因子筛选方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (fr) * 2013-07-21 2015-01-29 Whole Biome, Inc. Procédés et systèmes de caractérisation, de surveillance et de traitement du microbiome

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120149584A1 (en) * 2009-08-21 2012-06-14 Bernat Olle Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
US20130005586A1 (en) * 2010-03-01 2013-01-03 Stanislav Ehrlich Method of diagnostic of obesity
US20130045874A1 (en) * 2010-03-01 2013-02-21 Institut National De La Recherche Agronomique Method of Diagnostic of Inflammatory Bowel Diseases
AU2012332491A1 (en) * 2011-11-04 2014-05-29 General Mills, Inc. Methods and compositions for modulating gastrointestinal bacteria to promote health
JP2016509003A (ja) * 2013-02-04 2016-03-24 セレス セラピューティクス インコーポレイテッド 組成物および方法
WO2014190229A1 (fr) * 2013-05-24 2014-11-27 President And Fellows Of Harvard College Procédés d'isolation de microorganismes et leurs utilisations
US20150050245A1 (en) * 2013-08-14 2015-02-19 Tntgamble, Inc. Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora
WO2016065075A1 (fr) * 2014-10-21 2016-04-28 uBiome, Inc. Procédé et système de diagnostic et de thérapie fondés sur le microbiome
CA2964480A1 (fr) * 2014-10-31 2016-05-06 Whole Biome Inc. Procedes et compositions se rapportant a un traitement microbien et au diagnostic de troubles
CN107708716B (zh) * 2015-04-13 2022-12-06 普梭梅根公司 用于微生物组分类学特征相关的状况的微生物组来源的诊断和治疗的方法及系统
WO2016168364A1 (fr) * 2015-04-13 2016-10-20 uBiome, Inc. Procédé et système pour des diagnostics et des traitements thérapeutiques, dérivés du microbiome, de dysfonctionnements du système immunitaire
EP3283086A4 (fr) * 2015-04-13 2019-04-24 Ubiome Inc. Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome
CN107710205A (zh) * 2015-04-14 2018-02-16 优比欧迈公司 用于心血管疾病状况的微生物组来源的表征、诊断和治疗的方法及系统

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (fr) * 2013-07-21 2015-01-29 Whole Biome, Inc. Procédés et systèmes de caractérisation, de surveillance et de traitement du microbiome

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016168370A1 *
VIRILI CAMILLA ET AL: "Does microbiota composition affect thyroid homeostasis?", ENDOCRINE, HUMANA PRESS, INC, US, vol. 49, no. 3, 17 December 2014 (2014-12-17), pages 583 - 587, XP035520794, ISSN: 1355-008X, [retrieved on 20141217], DOI: 10.1007/S12020-014-0509-2 *

Also Published As

Publication number Publication date
CN107708714A (zh) 2018-02-16
AU2022200575A1 (en) 2022-02-17
AU2016250159A1 (en) 2017-11-09
EP3283087A1 (fr) 2018-02-21
CN107708714B (zh) 2022-07-22
WO2016168370A1 (fr) 2016-10-20

Similar Documents

Publication Publication Date Title
EP3347367A4 (fr) Procédé et système de diagnostic et de thérapie dérivés du microbiome pour la vaginose bactérienne
EP3515284A4 (fr) Appareil et procédé de dépistage
EP3520523A4 (fr) Procédé et appareil permettant de déterminer un groupe de ressources
EP3457378A4 (fr) Procédé et appareil de prédiction de vitesse
IL254867B (en) Improved device and method for extracting botanical oils
EP3342085C0 (fr) Procédé et appareil pour des transmissions à faible latence
EP3345127A4 (fr) Procédé et système pour surveiller des comportements de conduite
EP3306612A4 (fr) Procédé, appareil et système de traitement de karaoké
EP3519745A4 (fr) Panneau structural pour un appareil ayant des composants estampillés et son procédé
EP3379758A4 (fr) Procédé et appareil de transmission de service
EP3346910A4 (fr) Procédé et système pour diagnostics dérivés du microbiome et agents thérapeutiques contre l'eczéma
EP3372037C0 (fr) Procédés et appareil pour une liaison montante à plusieurs utilisateur
EP3313168A4 (fr) Système et procédé de traitement de semences prescriptif
EP3484349A4 (fr) Appareil, procédé et système de neuromodulation
GB201517076D0 (en) Method and apparatus for performing complex fourier transforms
EP3297874A4 (fr) Procédé et appareil de sécurité indépendante de véhicule
EP3515031A4 (fr) Système, appareil et procédé de traitement de session
EP3370539C0 (fr) Système d'adsorption et procédé permettant de faire fonctionner un système d'adsorption
EP3283085A4 (fr) Procédé et système pour diagnostics et thérapies dérivés du microbiome pour affections associées à des éléments taxonomiques du microbiome
EP3324824A4 (fr) Procédé, système et appareil pour le traitement de dysfonctionnements binoculaires
EP3283087A4 (fr) Procédé et système de diagnostics et de traitements dérivés du microbiome pour des dysfonctionnements du système endocrinien
EP3349407A4 (fr) Procédé permettant de supprimer l'auto-brouillage d'un appareil utilisant un système fdr
EP3554122A4 (fr) Appareil et procédé de transmission
EP3371683A4 (fr) Système et procédé de conception
BR112015005879A2 (pt) aparelho formador de imagens, e método para realizar uma tarefa de um aparelho formador de imagens.

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 19/18 20110101AFI20181026BHEP

Ipc: G16H 50/20 20180101ALI20181026BHEP

Ipc: G16H 50/70 20180101ALI20181026BHEP

Ipc: G16H 50/50 20180101ALI20181026BHEP

Ipc: C12Q 1/68 20180101ALI20181026BHEP

Ipc: G06F 19/24 20110101ALI20181026BHEP

Ipc: A61K 35/741 20150101ALI20181026BHEP

Ipc: G01N 33/48 20060101ALI20181026BHEP

Ipc: G01N 33/569 20060101ALI20181026BHEP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: C12Q0001680000

A4 Supplementary search report drawn up and despatched

Effective date: 20190207

RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/20 20180101ALI20190218BHEP

Ipc: G01N 33/48 20060101ALI20190218BHEP

Ipc: G01N 33/569 20060101ALI20190218BHEP

Ipc: G16H 50/50 20180101ALI20190218BHEP

Ipc: C12Q 1/68 20180101AFI20190218BHEP

Ipc: A61K 35/741 20150101ALI20190218BHEP

Ipc: G16H 50/70 20180101ALI20190218BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190910

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

D18D Application deemed to be withdrawn (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231024

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MACROGEN INC.